Literature DB >> 12140676

Localized (1)H magnetic resonance spectroscopy in mainly cortical gray matter of patients with multiple sclerosis.

P Sarchielli1, O Presciutti, R Tarducci, G Gobbi, A Alberti, G P Pelliccioli, P Chiarini, V Gallai.   

Abstract

The brain water fraction (R), the brain water transverse relaxation time (T2), the atrophy index (alpha) and the absolute concentration of the principal brain metabolites (NAA, Cho and Cr) were measured by localized proton magnetic resonance spectroscopy in the occipito-parietal cortex (mainly gray matter) of 15 relapsing-remitting (R-R) multiple sclerosis (MS) patients, 15 secondary progressive (SP) MS patients and 8 healthy subjects. Significantly lower values of N-acetylaspartate (NAA), creatine (Cr) and the NAA/Cr ratio in the occipito-parietal cortex were detected in SP MS patients than in R-R MS and control subjects (p < 0.01). Moreover, MS patients showed shorter T2 water relaxation times and reduced brain water fraction compared with controls. Higher atrophy indices were also detected in the mainly occipito-parietal gray matter of MS patients, particularly in those with the progressive form. These findings suggest that the pathological process in MS is not limited to either white matter lesions or normal-appearing white matter but extends into the cortical gray matter (occipito-parietal), particularly in the progressive form of the disease. This can involve changes in neural metabolism or neural shrinkage and neuron loss. The significant increase in atrophy indices could be the expression of the relatively higher cerebrospinal fluid signal from the occipito-parietal cortex, even in the absence of obvious cortical atrophy.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12140676     DOI: 10.1007/s00415-002-0758-5

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  13 in total

Review 1.  MRI evidence for multiple sclerosis as a diffuse disease of the central nervous system.

Authors:  Massimo Filippi; Maria Assunta Rocca
Journal:  J Neurol       Date:  2005-11       Impact factor: 4.849

2.  Relevance of the skewness index in DTI exploration of multiple sclerosis.

Authors:  Eliane Graulières; Jean-Albert Lotterie; Emmanuelle Cassol; Angélique Gerdelat; Michel Clanet; Isabelle Berry
Journal:  MAGMA       Date:  2008-11-08       Impact factor: 2.310

3.  Changes and variability of proton density and T1 relaxation times in early multiple sclerosis: MRI markers of neuronal damage in the cerebral cortex.

Authors:  René-Maxime Gracien; Sarah C Reitz; Stephanie Michelle Hof; Vinzenz Fleischer; Hilga Zimmermann; Amgad Droby; Helmuth Steinmetz; Frauke Zipp; Ralf Deichmann; Johannes C Klein
Journal:  Eur Radiol       Date:  2015-10-22       Impact factor: 5.315

4.  Relationships between gray matter metabolic abnormalities and white matter inflammation in patients at the very early stage of MS : a MRSI study.

Authors:  My Van Au Duong; Bertrand Audoin; Yann Le Fur; Sylviane Confort-Gouny; Irina Malikova; Elisabeth Soulier; Patrick Viout; André Ali-Cherif; Jean Pelletier; Patrick J Cozzone; Jean-Philippe Ranjeva
Journal:  J Neurol       Date:  2007-04-20       Impact factor: 4.849

Review 5.  Proton magnetic resonance spectroscopy in multiple sclerosis.

Authors:  Balasrinivasa R Sajja; Jerry S Wolinsky; Ponnada A Narayana
Journal:  Neuroimaging Clin N Am       Date:  2009-02       Impact factor: 2.264

6.  Gray matter N-acetyl aspartate deficits in secondary progressive but not relapsing-remitting multiple sclerosis.

Authors:  Elfar Adalsteinsson; Annette Langer-Gould; Ronald J Homer; Archana Rao; Edith V Sullivan; Christiane Abbehusen Lima; Adolf Pfefferbaum; Scott W Atlas
Journal:  AJNR Am J Neuroradiol       Date:  2003 Nov-Dec       Impact factor: 3.825

Review 7.  Axonal degeneration in multiple sclerosis: can we predict and prevent permanent disability?

Authors:  Jae Young Lee; Kasra Taghian; Steven Petratos
Journal:  Acta Neuropathol Commun       Date:  2014-08-27       Impact factor: 7.801

8.  Metabolite changes in early relapsing-remitting multiple sclerosis. A two year follow-up study.

Authors:  M Tiberio; D T Chard; D R Altmann; G Davies; C M Griffin; M A McLean; W Rashid; J Sastre-Garriga; A J Thompson; D H Miller
Journal:  J Neurol       Date:  2005-11-24       Impact factor: 4.849

9.  Magnetic resonance spectroscopy of normal appearing white matter in early relapsing-remitting multiple sclerosis: correlations between disability and spectroscopy.

Authors:  Juan Luis Ruiz-Peña; Pilar Piñero; Guillermo Sellers; Joaquín Argente; Alfredo Casado; Jesus Foronda; Antonio Uclés; Guillermo Izquierdo
Journal:  BMC Neurol       Date:  2004-06-10       Impact factor: 2.474

Review 10.  Systematic imaging review: Multiple Sclerosis.

Authors:  Aparna Katdare; Meher Ursekar
Journal:  Ann Indian Acad Neurol       Date:  2015-09       Impact factor: 1.383

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.